{"id":917111,"date":"2025-12-08T02:29:23","date_gmt":"2025-12-08T07:29:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/"},"modified":"2025-12-08T02:29:23","modified_gmt":"2025-12-08T07:29:23","slug":"moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/","title":{"rendered":"MoonLake Immunotherapeutics Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n LOS ANGELES<\/span>
\n <\/span>, Dec. 8, 2025<\/span><\/span> \/PRNewswire\/ — The DJS Law Group<\/a> \u00a0reminds investors of a class action lawsuit against \u00a0MoonLake Immunotherapeutics (“MoonLake ” or “the Company”) (NASDAQ: MLTX<\/a> ) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b<\/span>-5 promulgated thereunder by the U.S. Securities and Exchange Commission.<\/p>\n

Shareholders who purchased shares of MLTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n

\n CLASS PERIOD: <\/b> \u00a0March 10, 2024 to September 29, 2025<\/span><\/p>\n

\n DEADLINE: <\/b>
\n December 15, 2025<\/span>\n <\/p>\n

\n CASE DETAILS: <\/b> According to the Complaint, the Company made false and misleading statements to the market. MoonLake claimed its sonelokimab (SLK) drug was superior to competing therapies without any proven advantages. When the Company released the results of its Phase 3 trial, analysts labeled them “disastrous.” Based on these facts, MoonLake’s public statements were false and materially misleading throughout the class period.<\/p>\n

If you are a shareholder who suffered a loss, contact us to participate<\/a> .<\/p>\n

\n NEXT STEPS FOR SHAREHOLDERS <\/b> : Once you register as a shareholder who purchased shares during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. There is no cost or obligation to you to participate in this case.<\/p>\n

\n WHY DJS LAW GROUP? <\/b> \u00a0DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic\/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.<\/p>\n

\n Join the case<\/a> to recover your losses.<\/p>\n

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n

\n CONTACT: <\/b>\n <\/p>\n

\n David J. Schwartz<\/span>\n <\/p>\n

DJS Law Group<\/p>\n

274 White Plains Road, Suite 1<\/p>\n

\u00a0Eastchester, NY 10709<\/p>\n

Phone: 914-206-9742<\/p>\n

Email: David@djslawllp.com<\/a><\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/moonlake-immunotherapeutics-sued-for-securities-law-violations—contact-the-djs-law-group-to-discuss-your-rights–mltx-302634928.html<\/a><\/p>\n

SOURCE DJS Law Group LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire LOS ANGELES , Dec. 8, 2025 \/PRNewswire\/ — The DJS Law Group \u00a0reminds investors of a class action lawsuit against \u00a0MoonLake Immunotherapeutics (“MoonLake ” or “the Company”) (NASDAQ: MLTX ) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MLTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: \u00a0March 10, 2024 to September 29, 2025 DEADLINE: December 15, 2025 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. … <\/p>\n

Continue reading “MoonLake Immunotherapeutics Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-917111","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire LOS ANGELES , Dec. 8, 2025 \/PRNewswire\/ — The DJS Law Group \u00a0reminds investors of a class action lawsuit against \u00a0MoonLake Immunotherapeutics (“MoonLake ” or “the Company”) (NASDAQ: MLTX ) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MLTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: \u00a0March 10, 2024 to September 29, 2025 DEADLINE: December 15, 2025 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. … Continue reading "MoonLake Immunotherapeutics Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-08T07:29:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA41125&sd=2025-12-08\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MoonLake Immunotherapeutics Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX\",\"datePublished\":\"2025-12-08T07:29:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\\\/\"},\"wordCount\":370,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/edge.prnewswire.com\\\/c\\\/img\\\/favicon.png?sn=LA41125&sd=2025-12-08\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\\\/\",\"name\":\"MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/edge.prnewswire.com\\\/c\\\/img\\\/favicon.png?sn=LA41125&sd=2025-12-08\",\"datePublished\":\"2025-12-08T07:29:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\\\/#primaryimage\",\"url\":\"https:\\\/\\\/edge.prnewswire.com\\\/c\\\/img\\\/favicon.png?sn=LA41125&sd=2025-12-08\",\"contentUrl\":\"https:\\\/\\\/edge.prnewswire.com\\\/c\\\/img\\\/favicon.png?sn=LA41125&sd=2025-12-08\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MoonLake Immunotherapeutics Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/","og_locale":"en_US","og_type":"article","og_title":"MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX - Market Newsdesk","og_description":"PR Newswire LOS ANGELES , Dec. 8, 2025 \/PRNewswire\/ — The DJS Law Group \u00a0reminds investors of a class action lawsuit against \u00a0MoonLake Immunotherapeutics (“MoonLake ” or “the Company”) (NASDAQ: MLTX ) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MLTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: \u00a0March 10, 2024 to September 29, 2025 DEADLINE: December 15, 2025 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. … Continue reading \"MoonLake Immunotherapeutics Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-08T07:29:23+00:00","og_image":[{"url":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA41125&sd=2025-12-08","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MoonLake Immunotherapeutics Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX","datePublished":"2025-12-08T07:29:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/"},"wordCount":370,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/#primaryimage"},"thumbnailUrl":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA41125&sd=2025-12-08","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/","name":"MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/#primaryimage"},"thumbnailUrl":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA41125&sd=2025-12-08","datePublished":"2025-12-08T07:29:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/#primaryimage","url":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA41125&sd=2025-12-08","contentUrl":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA41125&sd=2025-12-08"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-17\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MoonLake Immunotherapeutics Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/917111","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=917111"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/917111\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=917111"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=917111"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=917111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}